Donepezil Hydrochloride
Yasnal Contains the Active Substance Donepezil Hydrochloride, Which Belongs to a Group of Medications Called Acetylcholinesterase Inhibitors.
Donepezil, by Slowing Down the Breakdown of Acetylcholine, an Important Substance for Memory Function, Increases its Concentration in the Brain.
Yasnal is Used for the Symptomatic Treatment of Mild to Moderate Alzheimer's Disease. These Symptoms May Include Increasing Memory Loss, Disorientation, and Changes in Behavior.
Yasnal Can be Used by Adult Patients.
Before Starting Yasnal, Discuss with Your Doctor or Pharmacist if Any of the Following Situations Apply or Have Applied to the Patient:
The Patient Should Also Inform the Doctor if She is Pregnant or Thinks She May be Pregnant.
Yasnal is Not Indicated for Use in Children and Adolescents (Under 18 Years of Age).
Tell the Doctor or Pharmacist About All Medications the Patient is Currently Taking or Has Recently Taken, as Well as Any Medications the Patient Plans to Take.
It is Especially Important to Inform the Doctor About Taking Any of the Following Medications:
A Patient Who is to Undergo Surgery Requiring General Anesthesia Should Inform the Doctor that They are Taking Yasnal. Yasnal May Affect the Amount of Anesthetic Needed.
Yasnal Can be Used in Patients with Kidney Diseases and Mild to Moderate Liver Impairment. The Doctor Should be Informed About Kidney or Liver Diseases. Patients with Severe Liver Impairment Should Not Take Yasnal.
The Patient Should Provide the Doctor or Pharmacist with the Name and Address of the Caregiver. The Caregiver Will Help with Taking the Medication as Prescribed by the Doctor.
Food Does Not Affect the Action of Yasnal.
During Treatment with Yasnal, Do Not Consume Alcohol, as it May Change the Effect of the Medication.
If the Patient is Pregnant or Breastfeeding, Thinks She May be Pregnant, or Plans to Have a Child, She Should Consult a Doctor or Pharmacist Before Taking this Medication.
Taking Yasnal During Pregnancy is Contraindicated. Women Taking Yasnal Should Not Breastfeed.
Alzheimer's Disease May Impair the Ability to Drive and Operate Machinery, So Do Not Perform These Activities Until the Doctor Has Assessed that it is Safe for the Patient to Do So.
Additionally, Yasnal May Cause Fatigue, Dizziness, and Muscle Cramps. If Any of These Side Effects Occur, Do Not Drive or Operate Machinery.
If the Patient Has Been Diagnosed with an Intolerance to Some Sugars, the Patient Should Consult a Doctor Before Taking Yasnal.
This Medication Should Always be Taken as Directed by the Doctor. If in Doubt, Consult the Doctor or Pharmacist.
The Recommended Initial Dose is 5 mg, Taken Before Bedtime.
If the Patient Experiences Vivid Dreams, Nightmares, or Difficulty Falling Asleep (See Section 4), the Doctor May Recommend Taking Yasnal in the Morning.
After One Month, the Doctor May Increase the Dose to 10 mg, Taken Before Bedtime.
The Dose of Yasnal May Change Depending on the Duration of Treatment and the Doctor's Recommendations.
The Maximum Recommended Daily Dose is 10 mg. Do Not Change the Dose Without Consulting the Doctor.
Take the Tablet with a Glass of Water, in the Evening Before Going to Bed. If the Patient Experiences Vivid Dreams, Nightmares, or Difficulty Falling Asleep (See Section 4), the Doctor May Recommend Taking Yasnal in the Morning.
Yasnal is Not Recommended for Use in Children and Adolescents Under 18 Years of Age.
Patients with Kidney Impairment May Use a Similar Dosing Schedule as Patients with Normal Kidney Function.
In Patients with Mild to Moderate Liver Impairment, Dose Increases Should be Made According to Individual Patient Tolerance. There is a Lack of Data on the Use of Yasnal in Patients with Severe Liver Impairment.
If More Than the Recommended Dose of Yasnal is Taken, Immediately Inform the Doctor or Go to the Nearest Hospital. Bring this Package Leaflet and the Medication Packaging with You.
Symptoms of Overdose May Include: Severe Nausea, Vomiting, Salivation, Excessive Sweating, Bradycardia (Slow Heart Rate), Hypotension (Low Blood Pressure), Respiratory Depression, Collapse, and Seizures. Progressive Muscle Weakness May Also Occur, Which Can Lead to Death in the Event of Respiratory Muscle Weakness. Depending on the Symptoms, the Doctor Will Provide Appropriate Treatment.
In Such a Case, Take the Next Dose at the Scheduled Time.
Do Not Take a Double Dose to Make Up for the Missed Dose.
If Yasnal is Not Taken for More Than a Week, Consult the Doctor Before Taking the Medication Again.
Do Not Stop Taking the Medication Unless the Doctor Recommends it. After Stopping the Medication, the Benefits of Treatment Will Gradually Decrease.
If You Have Any Further Questions About Taking this Medication, Ask Your Doctor or Pharmacist.
The Doctor or Pharmacist Will Recommend How Long to Continue Taking the Medication. Regularly Visit the Doctor to Monitor the Treatment and Assess the Symptoms.
Like All Medications, Yasnal Can Cause Side Effects, Although Not Everybody Gets Them.
The Following Side Effects Have Been Reported in Patients Taking Yasnal.
Severe Side Effects:
If the Patient Experiences Any of the Following Severe Side Effects, Immediately Inform the Doctor. Immediate Medical Attention May be Required.
Other Side Effects Include:
Very Common Side Effects (May Occur in More Than 1 in 10 Patients):
Common Side Effects (May Occur in Less Than 1 in 10 Patients):
Uncommon Side Effects (May Occur in Less Than 1 in 100 Patients):
Rare Side Effects (May Occur in Less Than 1 in 1000 Patients):
Unknown (Frequency Cannot be Estimated from the Available Data):
Reporting Side Effects
If Any Side Effects Occur, Including Those Not Listed in this Package Leaflet, Inform the Doctor or Pharmacist. Side Effects Can be Reported Directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side Effects Can Also be Reported to the Marketing Authorization Holder.
Reporting Side Effects Will Help to Gather More Information on the Safety of the Medication.
Store the Medication in a Place Out of Sight and Reach of Children.
Do Not Use this Medication After the Expiration Date Stated on the Packaging. The Expiration Date is the Last Day of the Specified Month.
There are No Special Storage Precautions.
Do Not Dispose of Medications via Wastewater or Household Waste. Ask Your Pharmacist How to Dispose of Medications That are No Longer Needed. This Will Help Protect the Environment.
5 mg: White or Almost White, Round, Biconvex Film-Coated Tablets
10 mg: Yellow-Brown, Round, Biconvex Film-Coated Tablets
Packaging:28 or 84 Film-Coated Tablets in Blister Packs, in a Cardboard Box
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
To Obtain More Detailed Information, Contact the Local Representative of the Marketing Authorization Holder:
Krka Polska Sp. z o.o.
Równoległa 5
02-235 Warsaw
Poland
Phone: +48 22 573 75 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.